4//SEC Filing
Wong Jerome 4
Accession 0001549084-23-000044
CIK 0001549084other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 9:59 PM ET
Size
7.2 KB
Accession
0001549084-23-000044
Insider Transaction Report
Form 4
Wong Jerome
Chief Financial Officer
Transactions
- Award
Common Stock
2023-06-12+170,068→ 271,537 total - Award
Common Stock
2023-06-12+8,200→ 11,413 total(indirect: By 401(k))
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
- [F2]The RSU grant was approved by the Compensation Committee of the Board of Directors in a meeting held on December 5, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of December 5, 2023, 2024 and 2025, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
- [F3]Includes 265,401 unvested RSUs.
Documents
Issuer
EKSO BIONICS HOLDINGS, INC.
CIK 0001549084
Entity typeother
Related Parties
1- filerCIK 0001932326
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 9:59 PM ET
- Size
- 7.2 KB